Outcomes of patients with malignant esophagogastric junction obstruction receiving metallic stents: A single-center experience
| Autor: | Ming-Chih Hou, Kuei-Chuan Lee, Pei-Shan Wu, Bing-Wei Ye, Yu-Ling Pan, Yi Hsiang Huang, Chung-Pin Li, I-Cheng Lee |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Adult
Male medicine.medical_specialty medicine.medical_treatment Technical success Single Center Stent patency Neoplasms Outcome Assessment Health Care medicine Humans In patient cardiovascular diseases Esophagogastric junction Aged Retrospective Studies Aged 80 and over Duodenal stents business.industry General Medicine Middle Aged equipment and supplies Dysphagia Surgery Radiation therapy surgical procedures operative Female Stents Duodenal Obstruction Esophagogastric Junction medicine.symptom business |
| Zdroj: | Journal of the Chinese Medical Association : JCMA. 85(2) |
| ISSN: | 1728-7731 |
| Popis: | BACKGROUND Malignancies-related esophagogastric junction (EGJ) obstruction is usually diagnosed in inoperable status with poor clinical outcomes. Metallic stent placement at EGJ could improve dysphagia for these patients. However, studies regarding the outcomes in these patients receiving metallic stents are still limited. This study aimed to investigate the outcomes of metallic stent placement in malignant EGJ obstruction. METHODS Forty-one patients with inoperable malignant EGJ obstruction receiving metallic stent placement were retrospectively enrolled. The clinical outcomes between different stents and deployment techniques were analyzed. RESULTS The overall technical success rate was 97.6% and clinical success rate was 92.1%. The median overall survival time was 77 (4-893) days, and the patency time was 71 (4-893) days, respectively. Post-stent radiotherapy significantly prolonged survival and stent patency. Between patients receiving uncovered or partially covered metal stents, there was no difference in procedure-related complications, survival time and stent patency time. Moreover, the clinical outcomes in patients receiving duodenal stents for malignant EGJ obstruction is not inferior to those receiving esophageal stents. CONCLUSION This study provides crucial information for endoscopists to establish individualized stenting strategies for malignant EGJ obstruction. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|